Skip to main content
. 2017 Dec 1;7:16784. doi: 10.1038/s41598-017-17021-w

Figure 3.

Figure 3

Lck inhibition induces expression of S1PR1 on CLL cells and their migration toward S1P. (a) CLL cells from 10 cases were examined immediately, or were cultured for 16 h with either idelalisib (1 μM), Lck-i (1 μM) or left untreated. All cells were examined by flow cytometry for S1PR1 levels. (b) CLL cells from four patients were incubated for 16 h with idelalisib (1 μM), Lck-i (1 μM) or left untreated (None), and then examined for migration toward S1P using HUVEC-coated transwells. The data are presented as migration index which is the quotient of the number of CD19 + cells transmigrating in the presence of S1P divided by that in its absence. (c) CLL cells from four patients were cultured with ibrutinib (1 μM), Lck-i (1 μM) or left untreated (None), and examined for migration toward CCL21 using HUVEC-coated transwells. Data are presented normalised to the level of CCL21-induced migration observed with untreated cells which is taken to be 100%. Statistical significance for all parts of this figure was determined using a Student’s t-test for paired data.